SIRT1 and Duchenne muscular dystrophy: Further studies are needed to affirm the effectiveness of SIRT1 activation as a new therapeutic target in DMD patients, and below we summarize the effect of the treatments in skeletal muscles, cardiac tissue and diaphragm.